Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2b, Randomized Study to Evaluate the Efficacy and Safety of Subcutaneous MEDI-528 in Adults With Uncontrolled Asthma

NCT00968669 is registered in ClinicalTrials.gov with MedImmune LLC as lead sponsor.

NCT NCT00968669
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00968669 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2b, Randomized Study to Evaluate the Efficacy and Safety of Subcutaneous MEDI-528 in Adults With Uncontrolled Asthma
Lead sponsor
MedImmune LLC
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2009
Completion date
January 31, 2012
Enrollment
329 (actual)
Sites
57

Conditions

As the registry lists them; a condition with its own page is linked.

asthma